Geron Corp. (GERN)
1.57
+0.06
(+3.97%)
USD |
NASDAQ |
Mar 25, 16:00
1.575
0.00 (0.00%)
After-Hours: 20:00
Geron Free Cash Flow : -110.95M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ionis Pharmaceuticals, Inc. | -325.67M |
| Recursion Pharmaceuticals, Inc. | -380.44M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
| Plus Therapeutics, Inc. | -20.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.07M |
| Cash from Investing (Quarterly) | 21.14M |
| Cash from Financing (Quarterly) | 0.378M |
| Free Cash Flow Per Share (Quarterly) | -0.0331 |
| Free Cash Flow to Equity (Quarterly) | -22.39M |
| Free Cash Flow to Firm (Quarterly) | -14.77M |
| Free Cash Flow Yield | -10.60% |